Skip to contentA
Accendra Health Inc
A
ACHAccendra Health Inc Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.19B$2.19Bderived+3.2% vs Q4 2018 Net Income-$39.02M-$39.02MderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Accendra Health Inc · CIK 75252 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$284,730,000+317.1% Operating Incomederived$14,538,000N/M Operating Cash Flowderived$26,980,000N/M Free Cash Flowderived$15,785,000N/M Margins · derivedGross margin13.0%+9.8 pt vs Q4 2018
Operating margin0.7%+11.3 pt vs Q4 2018
Net margin-1.8%+10.6 pt vs Q4 2018
ended Dec 31, 2019 · filed Mar 4, 2020 · 64 d after period end